Komori
Meiwa (8103) · InitiativeAdvanced

Exploring New Businesses in Pharmaceutical-Related Development and Petroleum Business Development

First written in FY2019-Q1. 5 of 9 entries say "Restated". Latest entry: FY2025.

9entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q1 – FY2019RestatedFY2020-Q2 – FY2020-Q3ReframedFY20232018: 220182019: 420192020: 120202021: 020212022: 020222023: 120232024: 020242025: 12025
Same theme, other companies
New business exploration and incubation, and business development through investment, collaboration and M&AA theme 199 companies write about · 0 as a headwind · 203 as a tailwind

93 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 203 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025AdvancedAnnual report

    「While building a network through investments in impact and ESG investment funds, the company is conducting the internal training program “Meiwa Mirai Hub” as a human-resource development initiative aimed at creating new businesses, and is advancing efforts toward commercializing new businesses in multiple projects.」

    The previous policy of developing new businesses has been specified through investments in investment funds, training equivalent to developing intrapreneurs, and consideration of commercialising multiple projects.
  2. FY2023ReframedAnnual report

    「We will advance business development in new fields by strengthening our investment pipeline, developing and supporting intrapreneurs, promoting M&A, and co-creating with startups, with the aim of creating new businesses that can become core sources of revenue.」

    The previous policy of developing new businesses has been specified in the new medium-term management plan as business development initiatives involving an investment pipeline, intrapreneurs, M&A, and co-creation with startups.
  3. FY2020-Q3RestatedAnnual report

    「The Petroleum Business Development Business advanced the development of a new business and started transactions.」

    The Petroleum Business Development Business continues to be described as having advanced the development of a new business and started transactions.
  4. FY2020-Q2RestatedAnnual report

    「The Petroleum Business Development Business advanced the development of a new business and started transactions.」

    The Petroleum Business Development Business continues to be described as having advanced the development of a new business and started transactions.
  5. FY2020-Q1AdvancedAnnual report

    「• The Pharmaceutical-Related Development Business brought a new business to fruition.」

    A new business was brought to fruition in the Pharmaceutical-Related Development Business. The Petroleum Business Development Business also advanced the development of a new business and is described as having started transactions.
  6. FY2019RestatedAnnual report

    「• The Pharmaceutical-Related Development Business focused on developing new businesses.」

    The policy of focusing on developing new businesses in the Pharmaceutical-Related Development Business continues. The Petroleum Business Development Business, the second business, is also described as having focused on developing new businesses.
  7. FY2019-Q3RestatedAnnual report

    「The Pharmaceutical-Related Development Business focused on developing new businesses.」

    The policy of focusing on developing new businesses in the Pharmaceutical-Related Development Business continues.
  8. FY2019-Q2RestatedAnnual report

    「The Pharmaceutical-Related Development Business focused on developing new businesses.」

    The policy of focusing on developing new businesses in the Pharmaceutical-Related Development Business continues. The Petroleum Business Development Business is also described as having focused on developing new businesses.
  9. FY2019-Q1First statedAnnual report

    「The Pharmaceutical-Related Development Business focused on developing new businesses.」

    The Pharmaceutical-Related Development Business is focusing on developing new businesses. The Petroleum Business Development Business is likewise described as having focused on developing new businesses.
Moved together

"Stable, recurring profit distributions and higher dividends per share" moved the same way as this thread, in the same document, in 2 of its 9 moves.

2222★1234
  1. ★This thread
  2. 1Stable, recurring profit distributions and higher dividends per share2×
  3. 2Improving Capital Efficiency and Reducing Interest-Bearing Debt through Group Finance2×
  4. 3Business Expansion and Strengthening the Management Infrastructure Through Enhancing Our Capabilities and Taking on the Challenge of Growth2×
  5. 4Creating New Value Across Three Core Areas: Mobility, the Environment, and Daily Life2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Meiwa yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Exploring New Businesses in Pharmaceutical-Related Development and Petroleum Business Development | Meiwa Corporation (8103) | Komori